EHS
EHS

STAT Plus: Pharmalittle: CVS and Ohio battle over Medicaid data; AbbVie strikes another Humira biosimilar deal

Rise and shine, everyone, the middle of the week is here. You made it this far, so why not forge ahead, yes? As always, we are doing our best with the help of some cups of stimulation — we are quaffing hazelnut this morning — and invite you to join us. After all, a prescription is not required, so go ahead and indulge. Meanwhile, we have assembled the latest menu of tidbits to get you started on another busy day. Hope all goes well and you conquer the world. Cheers …

CVS Caremark (CVS) is suing the Ohio Department of Medicaid to block release of a full report detailing how the pharmacy benefit manager charged taxpayers up six times as much to process prescription drugs as the industry standard, The Columbus Dispatch reports. Medicaid officials previously released an executive summary, arguing the full report contained proprietary information and could not be released under state public record laws. The release is being delayed while a judge reviews claims by CVS Caremark the analysis contains confidential information and trade secrets.

Continue to STAT Plus to read the full story…

EHS
Back to top button